Elevance Health, Inc. - Understand $elv stock

$ELV Market Cap: $92.79 Billion

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$174.2B

TTM

Gross Margin

89.58%

TTM

Net Earnings

$6.418B

TTM

Current Assets

$62.85B

Q3 2024

Current Liabilities

$42.03B

Q3 2024

Current Ratio

149.52%

Q3 2024

Total Assets

$116.5B

Q3 2024

Total Liabilities

$72.65B

Q3 2024

Book Value

$43.88B

Q3 2024

Cash

$7.866B

Q3 2024

P/E

14.46

Nov 29, 2024 EST

Free Cash Flow

$851.0M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Revenue	$171.3B	$156.6B	$138.6B	$121.9B	$104.2B	$92.11B	$90.04B	$84.86B	$79.16B	$73.87B	$71.02B	$61.50B	$60.71B	$58.70B	$65.39B	$61.25B	$61.17B	$57.06B	$44.61B	$20.71B	$16.78B	$13.29B	$10.45B	$8.771B	$6.270B
YoY Change	9.42%	12.95%	13.76%	16.94%	13.15%	2.29%	6.1%	7.21%	7.15%	4.01%	15.49%	1.3%	3.43%	-10.23%	6.76%	0.14%	7.2%	27.89%	115.44%	23.4%	26.25%	27.26%	19.09%	39.89%	10.35%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Revenue	$171.3B	$156.6B	$138.6B	$121.9B	$104.2B	$92.11B	$90.04B	$84.86B	$79.16B	$73.87B	$71.02B	$61.50B	$60.71B	$58.70B	$65.39B	$61.25B	$61.17B	$57.06B	$44.61B	$20.71B	$16.78B	$13.29B	$10.45B	$8.771B	$6.270B
Cost Of Revenue	$17.29B	$13.04B	$10.90B	$8.953B	$1.992B	$0.00	$0.00	$66.83B	$61.12B	$56.85B	$56.24B	$137.4M	$0.00	$0.00
Gross Profit	$154.0B	$143.6B	$127.7B	$112.9B	$102.2B	$92.11B	$90.04B	$18.03B	$18.04B	$17.02B	$14.79B	$61.36B	$60.71B	$58.70B
Gross Profit Margin	89.91%	91.68%	92.14%	92.65%	98.09%	100.0%	100.0%	21.24%	22.79%	23.04%	20.82%	99.78%	100.0%	100.0%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Selling, General & Admin	$20.09B	$17.69B	$15.91B	$17.45B	$13.36B	$14.02B	$12.65B	$12.56B	$12.53B	$11.75B	$9.953B	$8.681B	$8.436B	$8.733B	$9.019B	$8.497B	$8.702B	$8.818B	$7.273B	$3.478B	$3.098B	$2.515B	$1.986B	$1.808B	$1.469B
YoY Change	13.58%	11.13%	-8.8%	30.57%	-4.68%	10.83%	0.72%	0.19%	6.69%	18.04%	14.66%	2.9%	-3.4%	-3.18%	6.14%	-2.36%	-1.32%	21.24%	109.11%	12.27%	23.18%	26.64%	9.85%	23.08%	3.45%
% of Gross Profit	13.04%	12.32%	12.46%	15.45%	13.07%	15.22%	14.05%	69.66%	69.48%	69.03%	67.31%	14.15%	13.89%	14.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.745B	$1.675B	$136.0M	$176.0M	$147.0M	$124.0M	$111.0M	$104.0M	$105.8M	$106.5M	$107.9M	$107.1M	$95.70M	$103.1M	$553.0M	$571.0M	$586.0M	$605.0M	$557.0M	$269.0M	$245.0M	$157.0M	$121.0M	$102.0M	$62.00M
YoY Change	4.18%	1131.62%	-22.73%	19.73%	18.55%	11.71%	6.73%	-1.7%	-0.66%	-1.3%	0.75%	11.91%	-7.18%	-81.36%	-3.15%	-2.56%	-3.14%	8.62%	107.06%	9.8%	56.05%	29.75%	18.63%	64.52%	6.9%
% of Gross Profit	1.13%	1.17%	0.11%	0.16%	0.14%	0.13%	0.12%	0.58%	0.59%	0.63%	0.73%	0.17%	0.16%	0.18%
Operating Expenses	$162.6B	$148.0B	$15.91B	$17.45B	$13.36B	$14.02B	$12.65B	$12.56B	$12.53B	$11.75B	$9.953B	$8.681B	$8.436B	$8.733B	$56.83B	$57.52B	$55.46B	$51.74B	$40.50B	$18.91B	$15.44B	$12.39B	$9.832B	$8.387B	$6.065B
YoY Change	9.88%	829.84%	-8.8%	30.57%	-4.68%	10.83%	0.72%	0.19%	6.69%	18.04%	14.66%	2.9%	-3.4%	-84.63%	-1.2%	3.71%	7.19%	27.76%	114.12%	22.52%	24.59%	26.03%	17.23%	38.29%	13.03%
Operating Profit	$8.499B	$8.452B	$7.489B	$6.360B	$5.999B	$5.426B	$4.175B	$4.801B	$4.753B	$4.418B	$4.001B	$3.620B	$3.782B	$4.078B
YoY Change	0.56%	12.86%	17.75%	6.02%	10.56%	29.96%	-13.04%	1.01%	7.58%	10.42%	10.54%	-4.29%	-7.24%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Interest Expense	-$1.030B	-$851.0M	$798.0M	$784.0M	$746.0M	$753.0M	$739.0M	$723.0M	$653.0M	$600.7M	$602.7M	$511.8M	$430.3M	$418.9M	-$447.0M	-$470.0M	-$448.0M	-$404.0M	-$226.0M	-$142.0M	-$131.0M	-$99.00M	-$60.00M	-$55.00M	-$30.00M
YoY Change	21.03%	-206.64%	1.79%	5.09%	-0.93%	1.89%	2.21%	10.72%	8.71%	-0.33%	17.76%	18.94%	2.72%	-193.71%	-4.89%	4.91%	10.89%	78.76%	59.15%	8.4%	32.32%	65.0%	9.09%	83.33%	7.14%
% of Operating Profit	-12.12%	-10.07%	10.66%	12.33%	12.44%	13.88%	17.7%	15.06%	13.74%	13.6%	15.06%	14.14%	11.38%	10.27%
Other Income/Expense, Net
YoY Change

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Pretax Income	$7.715B	$7.769B	$7.925B	$6.238B	$5.985B	$5.068B	$3.964B	$4.555B	$4.631B	$4.368B	$3.840B	$3.858B	$3.958B	$4.354B	$7.403B	$3.122B	$5.258B	$4.914B	$3.890B	$1.443B	$1.212B	$803.0M	$525.0M	$330.0M	$61.00M
YoY Change	-0.7%	-1.97%	27.04%	4.23%	18.09%	27.85%	-12.97%	-1.64%	6.02%	13.75%	-0.47%	-2.52%	-9.09%	-41.19%	137.12%	-40.62%	7.0%	26.32%	169.58%	19.06%	50.93%	52.95%	59.09%	440.98%	-78.82%
Income Tax	$1.724B	$1.750B	$1.830B	$1.666B	$1.178B	$1.318B	$121.0M	$2.085B	$2.071B	$1.808B	$1.206B	$1.207B	$1.311B	$1.467B	$2.657B	$632.0M	$1.913B	$1.820B	$1.427B	$483.0M	$438.0M	$253.0M	$183.0M	$102.0M	$10.00M
% Of Pretax Income	22.35%	22.53%	23.09%	26.71%	19.68%	26.01%	3.05%	45.77%	44.72%	41.39%	31.4%	31.29%	33.13%	33.69%	35.89%	20.24%	36.38%	37.04%	36.68%	33.47%	36.14%	31.51%	34.86%	30.91%	16.39%
Net Earnings	$5.987B	$6.025B	$6.104B	$4.572B	$4.807B	$3.750B	$3.843B	$2.470B	$2.560B	$2.570B	$2.490B	$2.656B	$2.647B	$2.887B	$4.746B	$2.491B	$3.345B	$3.095B	$2.464B	$960.0M	$774.0M	$549.0M	$342.0M	$226.0M	$45.00M
YoY Change	-0.63%	-1.29%	33.51%	-4.89%	28.19%	-2.42%	55.59%	-3.52%	-0.38%	3.21%	-6.24%	0.33%	-8.33%	-39.17%	90.53%	-25.53%	8.08%	25.61%	156.67%	24.03%	40.98%	60.53%	51.33%	402.22%	-73.84%
Net Earnings / Revenue	3.49%	3.85%	4.4%	3.75%	4.61%	4.07%	4.27%	2.91%	3.23%	3.48%	3.51%	4.32%	4.36%	4.92%	7.26%	4.07%	5.47%	5.42%	5.52%	4.64%	4.61%	4.13%	3.27%	2.58%	0.72%
Basic Earnings Per Share	$25.38	$25.10	$25.04	$18.23	$18.81	$14.53	$14.70	$9.39	$9.73	$9.31	$8.34	$8.26	$7.35	$7.03
Diluted Earnings Per Share	$25.22	$24.81M	$24.73	$17.98	$18.47	$14.19	$14.35	$9.21	$9.38	$8.99	$8.20	$8.18	$7.25	$6.94	$9.867M	$4.763M	$5.556M	$4.821M	$3.936M	$3.048M	$2.725M	$2.250M	$1.644M	$1.087M	$218.4K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$6.526B	$7.387B	$4.880B	$5.741B	$4.937B	$3.934B	$3.609B	$4.075B	$2.114B	$2.152B	$1.582B	$2.475B	$2.202B	$1.789B	$4.816B	$2.184B	$2.768B	$2.602B	$2.740B	$1.457B	$465.0M	$695.0M	$406.0M	$203.0M	$204.0M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets														$911.0M	$880.0M	$1.534B	$997.0M	$1.173B	$744.0M	$732.0M	$326.0M	$204.0M	$170.0M	$252.0M	$206.0M
YoY Change														3.52%	-42.63%	53.86%	-15.0%	57.66%	1.64%	124.54%	59.8%	20.0%	-32.54%	22.33%
Property, Plant & Equipment	$4.359B	$4.316B	$4.547B	$4.129B	$3.708B	$2.735B	$2.175B	$1.978B	$2.020B	$1.944B	$1.802B	$1.717B	$1.418B	$1.156B	$1.100B	$1.055B	$996.0M	$989.0M	$1.079B	$1.045B	$511.0M	$537.0M	$402.0M	$429.0M	$409.0M
YoY Change	1.0%	-5.08%	10.12%	11.35%	35.58%	25.75%	9.96%	-2.08%	3.91%	7.88%	4.95%	21.09%	22.66%	5.09%	4.27%	5.92%	0.71%	-8.34%	3.25%	104.5%	-4.84%	33.58%	-6.29%	4.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$36.83B	$33.34B	$34.01B	$29.84B	$25.46B	$22.45B	$24.93B	$21.44B	$21.01B	$21.63B	$20.81B	$19.99B	$18.50B	$18.45B	$17.77B	$15.22B	$18.48B	$18.21B	$17.60B	$14.34B	$7.014B	$5.948B	$4.083B	$3.529B	$2.784B
YoY Change	10.45%	-1.95%	13.96%	17.19%	13.4%	-9.94%	16.26%	2.06%	-2.84%	3.9%	4.13%	8.08%	0.26%	3.8%	16.78%	-17.66%	1.49%	3.49%	22.75%	104.38%	17.92%	45.68%	15.7%	26.76%
Other Assets					$353.0M	$604.0M	$455.1M	$1.080B	$1.300B	$1.515B	$2.260B	$1.899B	$1.296B	$1.361B	$919.0M	$1.308B	$1.414B	$1.547B	$2.079B	$1.093B	$0.00	$195.0M	$40.00M	$90.00M	$100.0M
YoY Change					-41.56%	32.72%	-57.85%	-16.94%	-14.19%	-32.96%	19.01%	46.53%	-4.78%	48.1%	-29.74%	-7.5%	-8.6%	-25.59%	90.21%		-100.0%	387.5%	-55.56%	-10.0%
Total Long-Term Assets														$49.26B	$51.25B	$46.87B	$51.06B	$50.40B	$50.54B	$39.01B	$13.09B	$12.24B	$6.107B	$5.457B	$4.610B
YoY Change														-3.88%	9.34%	-8.21%	1.31%	-0.28%	29.58%	198.01%	6.98%	100.34%	11.91%	18.37%
Total Assets	$108.9B	$102.8B	$97.46B	$86.62B	$77.45B	$71.57B	$70.54B	$65.08B	$61.72B	$61.68B	$59.58B	$58.96B	$52.16B	$50.17B	$52.13B	$48.40B	$52.06B	$51.58B	$51.29B	$39.74B	$13.42B	$12.44B	$6.277B	$5.709B	$4.816B
YoY Change
Accounts Payable	$6.910B	$5.035B	$4.970B	$5.493B	$4.198B	$4.959B	$5.024B	$4.015B	$3.319B	$3.652B	$3.426B	$3.099B	$3.124B	$2.942B	$2.994B	$2.857B	$2.910B	$3.242B	$2.860B	$2.222B	$901.0M	$472.0M	$331.0M	$304.0M	$179.0M
YoY Change	37.24%	1.31%	-9.52%	30.85%	-15.35%	-1.3%	25.14%	20.97%	-9.12%	6.6%	10.55%	-0.8%	6.19%	-1.74%	4.8%	-1.82%	-10.24%	13.36%	28.71%	146.61%	90.89%	42.6%	8.88%	69.83%
Accrued Expenses	$849.0M	$932.0M	$997.0M	$957.0M	$640.0M
YoY Change	-8.91%	-6.52%	4.18%	49.53%
Deferred Revenue
YoY Change
Short-Term Debt	$225.0M	$265.0M	$275.0M	$0.00	$700.0M	$1.145B	$1.275B	$440.0M	$540.0M	$400.0M	$400.0M	$250.0M	$100.0M	$100.0M	$0.00	$98.00M	$0.00	$0.00	$0.00	$0.00	$0.00	$358.0M	$311.0M	$251.0M	$147.0M
YoY Change	-15.09%	-3.64%		-100.0%	-38.86%	-10.2%	189.77%	-18.52%	35.0%	0.0%	60.0%	150.0%	0.0%		-100.0%						-100.0%	15.11%	23.9%	70.75%
Long-Term Debt Due	$1.649B	$1.500B	$1.599B	$700.0M	$1.598B	$849.0M	$1.275B	$928.4M	$0.00	$624.0M	$518.0M	$557.0M	$1.275B	$706.0M	$61.00M	$910.0M	$20.00M	$521.0M	$481.0M	$161.0M
YoY Change	9.93%	-6.19%	128.43%	-56.2%	88.22%	-33.39%	37.29%		-100.0%	20.46%	-7.0%	-56.31%	80.59%	1057.38%	-93.3%	4450.0%	-96.16%	8.32%	198.76%
Total Short-Term Liabilities	$1.874B	$6.800B	$7.841B	$7.150B	$7.571B	$7.754B	$8.141B	$6.555B	$5.233B	$6.258B	$5.409B	$4.540B	$5.423B	$4.683B	$4.718B	$4.400B	$3.835B	$5.331B	$5.746B	$3.545B	$1.371B	$940.0M	$694.0M	$578.0M	$331.0M
YoY Change	-72.44%	-13.28%	9.66%	-5.56%	-2.36%	-4.75%	24.2%	25.26%	-16.38%	15.7%	19.14%	-16.28%	15.8%	-0.74%	7.23%	14.73%	-28.06%	-7.22%	62.09%	158.57%	45.85%	35.45%	20.07%	74.62%
Long-Term Debt	$23.25B	$22.35B	$21.16B	$19.34B	$17.79B	$17.22B	$17.38B	$14.36B	$15.33B	$14.02B	$13.57B	$14.17B	$8.466B	$8.148B	$8.338B	$7.834B	$9.024B	$6.493B	$6.325B	$4.290B	$1.663B	$1.659B	$818.0M	$598.0M	$522.0M
YoY Change	4.01%	5.63%	9.42%	8.7%	3.31%	-0.95%	21.06%	-6.31%	9.31%	3.29%	-4.21%	67.39%	3.9%	-2.28%	6.43%	-13.19%	38.98%	2.66%	47.44%	157.97%	0.24%	102.81%	36.79%	14.56%
Other Long-Term Liabilities	$28.29B	$11.25B	$8.535B	$6.910B	$4.472B	$4.372B	$4.268B	$4.465B	$3.810B	$2.897B	$2.692B	$2.990B	$2.783B	$3.227B	$3.555B	$3.676B	$4.409B	$3.415B	$3.211B	$3.246B	$1.408B	$1.094B	$598.0M	$631.0M	$646.0M
YoY Change	151.6%	31.75%	23.52%	54.52%	2.29%	2.43%	-4.41%	17.19%	31.52%	7.62%	-9.97%	7.44%	-13.76%	-9.23%	-3.29%	-16.63%	29.11%	6.35%	-1.08%	130.54%	28.7%	82.94%	-5.23%	-2.32%
Total Long-Term Liabilities	$51.54B	$33.59B	$29.69B	$26.25B	$22.26B	$21.59B	$21.65B	$18.82B	$19.14B	$16.92B	$16.27B	$17.16B	$11.25B	$11.38B	$11.89B	$11.51B	$13.43B	$9.908B	$9.536B	$7.536B	$3.071B	$2.753B	$1.416B	$1.229B	$1.168B
YoY Change	53.41%	13.14%	13.13%	17.91%	3.1%	-0.28%	15.02%	-1.63%	13.11%	4.0%	-5.22%	52.56%	-1.11%	-4.36%	3.33%	-14.32%	35.58%	3.9%	26.54%	145.39%	11.55%	94.42%	15.22%	5.22%
Total Liabilities	$69.62B	$66.47B	$61.40B	$53.42B	$45.73B	$43.03B	$44.04B	$39.98B	$38.67B	$37.43B	$34.81B	$35.15B	$28.88B	$26.35B	$27.26B	$26.97B	$29.07B	$27.00B	$26.29B	$20.28B	$7.415B	$7.077B	$4.217B	$3.789B	$3.155B
YoY Change	4.75%	8.25%	14.95%	16.82%	6.26%	-2.29%	10.14%	3.38%	3.34%	7.52%	-0.98%	21.74%	9.57%	-3.33%	1.08%	-7.22%	7.67%	2.68%	29.66%	173.49%	4.78%	67.82%	11.3%	20.1%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Basic Shares Outstanding	235.9M shares	240.0M shares	243.8M shares	250.8M shares	255.5M shares	258.1M shares	261.5M shares	262.9M shares	263.0M shares	275.9M shares	298.5M shares	321.5M shares	360.2M shares	410.9M shares
Diluted Shares Outstanding	237.4M shares	242.8M shares	246.8M shares	254.3M shares	260.3M shares	264.2M shares	267.8M shares	268.1M shares	272.9M shares	285.9M shares	303.8M shares	324.8M shares	365.1M shares	415.8M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $92.795 Billion

About Elevance Health, Inc.

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 104,900 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to Individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. The company also offers infusible and injectable therapies. Carelon Services offers healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.

Industry: Hospital & Medical Service Plans Peers: Alignment Healthcare, Inc. Progyny, Inc. CENTENE CORP CLOVER HEALTH INVESTMENTS, CORP. /DE HEALTHEQUITY, INC. HUMANA INC MOLINA HEALTHCARE, INC. PACIFIC HEALTH CARE ORGANIZATION INC UNITEDHEALTH GROUP INC